Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Nachtigall

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Expert Opinion on Pharmacotherapy|June 7, 2013
Current treatment options for hyperprolactinemiaAlexander Faje, Lisa Nachtigall
The Journal of Clinical Endocrinology and Metabolism|April 15, 2026
Current Controversies in Acromegaly CareJoanna L Spencer-Segal, Lisa Nachtigall
Clinical Endocrinology|September 9, 2021
The biochemical diagnosis of adrenal insufficiency with modern cortisol assays: Reappraisal in the setting of opioid exposure and hospitalizationCaitlin Colling, Lisa Nachtigall, Beverly M K Biller, et al.
The Journal of Clinical Endocrinology and Metabolism|April 3, 2008
Changing patterns in diagnosis and therapy of acromegaly over two decadesLisa Nachtigall, Adriano Delgado, Brooke Swearingen, et al.
Menopause (New York, N.Y.)|November 8, 2008
Association of oral but not transdermal estrogen therapy with enhanced platelet reactivity in a subset of postmenopausal womenRobert Flaumenhaft, Margaret Nachtigall, Joanna Lowenstein, et al.
The Journal of Clinical Endocrinology and Metabolism|August 10, 2013
Central diabetes insipidus: a previously unreported side effect of temozolomideAlexander T Faje, Lisa Nachtigall, Deborah Wexler, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 2014
Ipilimumab-induced hypophysitis: a detailed longitudinal analysis in a large cohort of patients with metastatic melanomaAlexander T Faje, Ryan Sullivan, Donald Lawrence, et al.
European Journal of Endocrinology|June 9, 2019
Hypophysitis secondary to nivolumab and pembrolizumab is a clinical entity distinct from ipilimumab-associated hypophysitisAlexander Faje, Kerry Reynolds, Leyre Zubiri, et al.
The Journal of Clinical Endocrinology and Metabolism|April 3, 2008
Growth hormone decreases visceral fat and improves cardiovascular risk markers in women with hypopituitarism: a randomized, placebo-controlled studyCatherine Beauregard, Andrea L Utz, Amber E Schaub, et al.
Neurosurgery|February 23, 2012
Transsphenoidal surgery for cushing disease after nondiagnostic inferior petrosal sinus samplingSameer A Sheth, Matthew K Mian, Jonathan Neal, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Expert Opinion on Pharmacotherapy|June 7, 2013
Current treatment options for hyperprolactinemiaAlexander Faje, Lisa Nachtigall
The Journal of Clinical Endocrinology and Metabolism|April 15, 2026
Current Controversies in Acromegaly CareJoanna L Spencer-Segal, Lisa Nachtigall
Clinical Endocrinology|September 9, 2021
The biochemical diagnosis of adrenal insufficiency with modern cortisol assays: Reappraisal in the setting of opioid exposure and hospitalizationCaitlin Colling, Lisa Nachtigall, Beverly M K Biller, et al.
The Journal of Clinical Endocrinology and Metabolism|April 3, 2008
Changing patterns in diagnosis and therapy of acromegaly over two decadesLisa Nachtigall, Adriano Delgado, Brooke Swearingen, et al.
Menopause (New York, N.Y.)|November 8, 2008
Association of oral but not transdermal estrogen therapy with enhanced platelet reactivity in a subset of postmenopausal womenRobert Flaumenhaft, Margaret Nachtigall, Joanna Lowenstein, et al.
The Journal of Clinical Endocrinology and Metabolism|August 10, 2013
Central diabetes insipidus: a previously unreported side effect of temozolomideAlexander T Faje, Lisa Nachtigall, Deborah Wexler, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 2014
Ipilimumab-induced hypophysitis: a detailed longitudinal analysis in a large cohort of patients with metastatic melanomaAlexander T Faje, Ryan Sullivan, Donald Lawrence, et al.
European Journal of Endocrinology|June 9, 2019
Hypophysitis secondary to nivolumab and pembrolizumab is a clinical entity distinct from ipilimumab-associated hypophysitisAlexander Faje, Kerry Reynolds, Leyre Zubiri, et al.
The Journal of Clinical Endocrinology and Metabolism|April 3, 2008
Growth hormone decreases visceral fat and improves cardiovascular risk markers in women with hypopituitarism: a randomized, placebo-controlled studyCatherine Beauregard, Andrea L Utz, Amber E Schaub, et al.
Neurosurgery|February 23, 2012
Transsphenoidal surgery for cushing disease after nondiagnostic inferior petrosal sinus samplingSameer A Sheth, Matthew K Mian, Jonathan Neal, et al.
Pageof 2